Identification of sepsis is a major issue due to limitations in diagnosis and severity of outcome. Different combinations of tests are used to screen babies at risk for infection, none specific enough to avoid treatment of noninfected newborns. 193 newborns with 35 weeks of gestational age admitted in the maternity were screened for infection using a protocol scoring system involving haematological values and CRP 10mg/l. Blood-cultures were taken after treatment decision, before antibiotics were started. No microbiological exam was included in the screening. Treatment decisions were taken by the staff irrespectively of the ongoing observational study.
INTRODUCTION
Identification of early neonatal sepsis is a major issue due to limitations in diagnostic procedures and severity of the outcome. The gold-standard positive blood-culture has very low sensitivity [1] . Minimising antibiotic exposure without risk is not an easy task [2] [3] [4] [5] . Different screening tests and combination of tests including acute-phase reactants, haematological scoring systems (HSS) and, recently, cytokines, are used, the optimal selection of which is yet to be determined. Cost can also be limiting. Good negative predictive values can be obtained at 12 -24h of life (99%) [6] with C-reactive protein (CRP) and HSS but specificity is generally not good enough to avoid treating non infected newborns [7] [8] [9] . Newborns generally have a physiological induction of inflammation values in the first few days after birth, and a moderate elevation of acute-phase reactants does not necessarily indicates sepsis. Cut-off levels of CRP vary among authors from 5 to 50mg/l [10] [11] [12] [13] [14] . CRP increases in 4-6h after an inflammatory trigger and peaks around 36-50h. Error of the negative predictive value of CRP screening at birth (cord blood) is 12% and sensitivity 20%, making it not useful by that time [15] .
The authors evaluated the screening protocol in use at the maternity ward of Santa Maria University Hospital in Lisbon, proposed a new cut-off level for CRP and present the follow-up after changes have been implemented.
STUDY DESIGN
The authors evaluated the cut-off level of CRP as a septic marker in use in the maternity ward. All newborns with 35 weeks of gestational age (GA) at risk for infection admitted during 2006 were enrolled prospectively. Treatment decisions were taken by the staff irrespectively of the ongoing observational study. By then, the protocol for septic screening involved a scoring system (positive 2) including CRP and leukocyte count. (Table 1 ). Reference range in our laboratory for a negative CRP is < 5mg/l.
A negative screening by 24h of age was not repeated. Results from CRP and HSS were evaluated until a decision was taken. Blood-cultures were done only after a positive treatment decision, before antibiotics were started. No peripheral or gastric fluid microbiological exam was included as part of the screening tests. 
CRP (mg/L) 10 20
Leukocyte count/mm 3 <7500 or >30000 < 5000 or > 40000
Neutrophil count/mm 3 
< 1500 < 1000
Immature N/Total Neutrophil 0,2 0,3
Newborns were afterwards classified by the authors in four groups: infected (culture verified), strongly suspected infection (SSI) no sepsis but treated (NST), no sepsis-no treatment (NSNT).
To classify a newborn as SSI it was necessary to meet at least one of the following criteria: CRP > 50 mg/l, positive screening score in the baby and multiple risk factors, positive screening score and clinical alteration, readmission for sepsis within one week after discharge (telephone control).
The authors revaluated treatment decision for each newborn according to different cut-off levels of CRP within each group.
RESULTS
From the 2771 births at Santa Maria University Hospital during 2006, 2478 NB were admitted in the maternity ward (well babies). 193 presented risk for infection. 50.3% were girls. Mean GA was 38,7 weeks (SD 1.4), 37% born by caesarean section. Risk factors were: mother colonization with group B Streptococcus without correct prophylaxis -33%, prolonged rupture of membranes ( 18h) -46%, maternal fever during labour ( 38ºC) -17%, amnionitis -3%, documented recent urinary tract infection (last week before birth) without treatment -8%; multiple risk factors -11%. Spontaneous prematurity by itself was not considered a risk factor for screening. 40 newborns (20.7% from those considered at risk) received antibiotics. The number of analysis before a decision was taken to treat or not to treat varied from one to four. Six babies were lost for the followup.
From the 187 babies with complete follow-up, two had positive blood-cultures. This represented 5% of the blood cultures. Bacteria identified were Lysteria monocytogenes in one case and Staphylococcus aureus in the other. 13 newborns (7%) were classified as strongly suspected of infection (all of them treated), 25 babies (13.4%) were classified by the authors as not infected but treated and 147 (78.6%) were classified as not infected and not treated. All infected newborns were identified (negative predictive value 100%) but the error of the positive predictive value reached 62.5%.
CRP in the moment of decision varied from 1 to 16mg/l for not treated newborns and 10 to 151mg/l for treated ones. CRP for infected and SSI (all treated) varied between 22 and 151mg/l; for NST babies from 10 to 48mg/l. 1 to 4 blood analyses were done before reaching a decision, within the first 72h of age. No infant was readmitted for sepsis.
Revaluating the CRP level in the scoring system showed that the use of 15mg/l as the cut-off level would have screened for treatment 23 NB not infected without missing any SSI, reducing the error of the positive predictive value to 60.5%. Cut-off level at 20mg/l would have screened for treatment 16 not infected NB without missing any SSI with a reduction of the error of the positive predictive value to 51.6%. A cut-off level at 25mg/l would have screened for treatment 12 newborns not infected (error of the positive predictive value 48%) but would have missed 2 strongly suspected (error of the negative predictive value of 1.3%). (Table 2) Error of the negative predictive value: 2/162 = 1.2%. Error of the positive predictive value: 12/25= 48%.
DISCUSSION
Staphylococcus aureus is not a frequent agent of earlyonset neonatal sepsis and several authors in different studies consider it as a contaminant. Nevertheless we decided to classify the baby with the blood culture positive for that agent as infected. He also had a positive score and the same agent was identified in his mother's urine in the context of a urinary tract infection.
From the 187 newborns included in the study, 172 were posteriorly considered as probably not infected. Using CRP cut-off levels of 15mg/l and 20mg/l, 23 and 16 newborns would have been unnecessarily treated, respectively, without missing any strongly suspected of infection. The cut-off level of 25mg/l was dismissed as it would have missed two babies with strongly suspected infection.
A new scoring system was therefore proposed based in CRP at 20mg/l, HSS (values by hours of age) [16] and clinical symptoms that has been in use since then without readmissions for infection and an estimated reduction of 24% antibiotic treatment of newborns at risk for early onset sepsis not infected.
Recommendations from the Center for Diseases Control regarding B Streptococcus infection prophylaxis during labour have changed since 2010 and fewer babies would have been screened according to the new guidelines [6, 17] . Therefore some of the screened newborns were probably not really at risk, but they were probably in the group "not infected and not treated", without major alteration in the estimated reduction of antibiotic treatment.
A faster marker like procalcitonin may be useful, avoiding repeated screening. Time adjusted reference range must be used for the first few days of life but a low level at birth (cord blood) seems to have a very high negative predictive value [18, 19] . Other promising markers currently being evaluated like neutrophil CD64 and interleukine 6 [20, 21] lack evidence based results to substitute old markers and represent an important additional cost. This paper specifically addresses the screening of asymptomatic neonates at risk for early sepsis. This represents about 10% of term and late preterm newborns. If we admit that only about 0.5 to 1% of asymptomatic newborns will effectively be infected and also that these babies are at increased risk for secondary effects of antibiotic treatment but also at risk for a rapid and fatal evolution if infected, it is important to develop strategies to target treatment as best as we can.
This study, as most addressing the same subject, is limited by the fact that withholding treatment is difficult to accept or clearly not possible according to present protocols and starting treatment obviously interferes with evolution, both clinical and laboratorial.
A negative blood culture has a small negative predictive value; Therefore it is difficult or impossible to really distinguish infected from non infected newborns without undue risk for the babies.
The threshold of 20mg/L for C reactive-protein within 24 -72h of age seems the best negative predictor, not compromising newborn safety.
